A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
Public ClinicalTrials.gov record NCT01327053. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II, Randomized Double-blind Study of Efficacy and Safety of Two Dose Levels of LDE225 in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study assessed the efficacy and safety of oral treatment with two dose levels of LDE225 in patients with locally advanced or metastatic BCC.
Study identification
- NCT ID
- NCT01327053
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 230 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 29, 2011 (Actual)
- Primary completion
- Jun 28, 2013 (Actual)
- Completion
- Jun 29, 2018 (Actual)
- Last update posted
- Aug 28, 2019
2011 – 2018
United States locations
- U.S. sites
- 22
- U.S. states
- 15
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Highlands Oncology Group | Fayetteville | Arkansas | 72703 | — |
| University of California at Los Angeles UCLA 3 | Los Angeles | California | 90095 | — |
| Stanford University Medical Center Stanford Univ 2 | Stanford | California | 94304 | — |
| University of Colorado School of Medicine UC | Aurora | Colorado | 80045 | — |
| Washington Hospital Center Wash Hospital | Washington D.C. | District of Columbia | 20010 | — |
| H Lee Moffitt Cancer Center and Research Institute Cutaneous Onc Dept | Tampa | Florida | 33612 | — |
| NorthwesternUniv.Med.School/Robert H. Lurie Comp.Cancer Ctr Study coordinator | Chicago | Illinois | 60611 | — |
| Dana Farber Cancer Institute DFCI - MA | Boston | Massachusetts | 02215 | — |
| Henry Ford Hospital Henry Ford | Detroit | Michigan | 48202 2689 | — |
| Washington University School Of Medicine-Siteman Cancer Ctr Siteman | St Louis | Missouri | 63110 | — |
| Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) | Las Vegas | Nevada | 89109 | — |
| Hackensack University Medical Center Hackensack (SC) | Hackensack | New Jersey | 07601 | — |
| New York University Medical Center SC-2 | New York | New York | 10016 | — |
| Penn State University / Milton S. Hershey Medical Center Hershey Medical | Hershey | Pennsylvania | 17033-085 | — |
| University of Pittsburgh Medical Center UPMC | Pittsburgh | Pennsylvania | 15213 | — |
| Baylor Health Care System/Sammons Cancer Center Baylor Texas Oncology | Dallas | Texas | 75246 | — |
| Texas Oncology Tex Onc 3 | Dallas | Texas | 75246 | — |
| Texas Oncology Texas Onc - Amarillo | Dallas | Texas | 75246 | — |
| University of Texas MD Anderson Cancer Center MD Anderson | Houston | Texas | 77030 | — |
| Texas Oncology Cancer Care & Research Center | Waco | Texas | 76712 | — |
| Texoma Cancer Center Texoma Cancer Center | Wichita Falls | Texas | 76310 | — |
| University of Utah / Huntsman Cancer Institute Huntsman/Univ UT | Salt Lake City | Utah | 84103 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01327053, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 28, 2019 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01327053 live on ClinicalTrials.gov.